80 related articles for article (PubMed ID: 16060087)
1. Oxidative stress in patients with coronavirus disease and end-stage renal disease: a pilot study.
Beck NS; Seo Y; Park T; Jun SS; Im JI; Hong SY
BMC Nephrol; 2024 May; 25(1):155. PubMed ID: 38702607
[TBL] [Abstract][Full Text] [Related]
2. Biomonitoring of Oxidative-Stress-Related Genotoxic Damage in Patients with End-Stage Renal Disease.
Yüzbaşıoğlu Y; Hazar M; Aydın Dilsiz S; Yücel C; Bulut M; Cetinkaya S; Erdem O; Basaran N
Toxics; 2024 Jan; 12(1):. PubMed ID: 38251024
[TBL] [Abstract][Full Text] [Related]
3. [Nephroprotective value of N-acetylcysteine for patients with concomitant trauma, as well as other aspects of the use of this drug in clinical practice].
Miziev I A; Makhov M K; Makhova A B; Shiritova L A; Gubzhokova L B
Urologiia; 2024 Mar; (1):129-134. PubMed ID: 38650418
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?
Liakopoulos V; Roumeliotis S; Bozikas A; Eleftheriadis T; Dounousi E
Oxid Med Cell Longev; 2019; 2019():9109473. PubMed ID: 30774749
[TBL] [Abstract][Full Text] [Related]
5. The Assessment of the Integrated Antioxidant System of the Body in the Course of Radon Therapy: A Pilot Study.
Kuciel-Lewandowska J; Gnus J; Pawlik-Sobecka L; Płaczkowska S; Kokot I; Kasperczak M; Paprocka-Borowicz M
Biomed Res Int; 2018; 2018():6038106. PubMed ID: 29487870
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.
Nakayama A; Alladin KP; Igbokwe O; White JD
Cancer Invest; 2011 Dec; 29(10):655-67. PubMed ID: 22085269
[TBL] [Abstract][Full Text] [Related]
7. The Combined Antioxidant Effects of N-Acetylcysteine, Vitamin D3, and Glutathione from the Intestinal-Neuronal In Vitro Model.
Mulè S; Ferrari S; Rosso G; Brovero A; Botta M; Congiusta A; Galla R; Molinari C; Uberti F
Foods; 2024 Mar; 13(5):. PubMed ID: 38472887
[TBL] [Abstract][Full Text] [Related]
8. Allo-HCT: damaged T cells don't bite.
Apostolova P
Blood; 2023 Mar; 141(13):1507-1508. PubMed ID: 36995707
[No Abstract] [Full Text] [Related]
9. The molecular mechanisms of hemodialysis vascular access failure.
Brahmbhatt A; Remuzzi A; Franzoni M; Misra S
Kidney Int; 2016 Feb; 89(2):303-316. PubMed ID: 26806833
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cytokine synthesis as a consequence of increased intracellular oxidative stress in children treated with dialysis.
Zachwieja J; Zaniew M; Runowski D; Lewandowska-Stachowiak M; Stefaniak E; Siwińska A
Nephron Clin Pract; 2005; 101(2):c100-8. PubMed ID: 15956803
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants in the treatment of patients with renal failure.
Luciak M
Rocz Akad Med Bialymst; 2004; 49():157-61. PubMed ID: 15631333
[TBL] [Abstract][Full Text] [Related]
13. [Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach?].
Cristol JP; Maggi MF; Bosc JY; Badiou S; Delage M; Vernet MH; Michel F; Castel J; Canaud B; Descomps B
C R Seances Soc Biol Fil; 1997; 191(4):603-16. PubMed ID: 9404462
[TBL] [Abstract][Full Text] [Related]
14. [Influence of vitamin E and N-acetylcysteine on intracellular oxidative stress in T lymphocytes in children treated with dialysis].
Zaniew M; Zachwieja J; Warzywoda A; Stefaniak E; Runowski D; Lewandowska-Stachowiak M
Wiad Lek; 2005; 58 Suppl 1():58-65. PubMed ID: 16060087
[TBL] [Abstract][Full Text] [Related]
15. [The antioxidant therapy modulates intracellular lymphokine expression in children on dialysis].
Zaniew M; Zachwieja J; Lewandowska-Stachowiak M; Sobczyk D; Siwińska A
Przegl Lek; 2006; 63 Suppl 3():63-7. PubMed ID: 16898491
[TBL] [Abstract][Full Text] [Related]
16. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
